Pufferfish (fugu) sushi wih CD-stabilized sauce
In the world of Japanese culinary culture, few ingredients carry as much mystique as fugu, the infamous pufferfish delicacy known
Effect of CD on the antiaging drug: rapamycin
Rapamycin (also known as sirolimus) is a macrolide compound produced by the bacterium Streptomyces hygroscopicus. It is immunosuppressant used to
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of
Cyclodextrins at HPLC 2019 Milan
HPLC 2019, the most important international conference in the field of high-performance liquid phase separations and related techniques, will be
International Cyclodextrin Symposium 2020
The conference will be held in May 26-29, 2020 in Giardini Naxos (Messina, Sicily) organized by the National Council of
INTERPHEX
April 2-4, 2019, New York For 40 years, INTERPHEX has proven to be the place to find all of the
Phase I clinical trial posted on Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection
This study is designed to compare the bioavailability of the test Product (CE-Iohexol Injection) and the reference product Iohexol Injection
Poster competition at the 4th International Summer School on Cyclodextrins
The 4th International Summer School on Cyclodextrins will be held in Milano on 10-12 June 2019. A poster session will
CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo (TM) in Alzheimer’s Disease
CTD Holdings, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical
Sage Therapeutics Announces FDA Approval of ZULRESSO™ (SBECD-enabled brexanolone) Injection, the First and Only Treatment Specifically Indicated for Postpartum Depression
Approval based on results from three pivotal trials showing treatment with ZULRESSO provided significant and rapid reduction of depressive symptoms
Might cyclodextrin uptake mask antimicrobial activity?
Could excipients mask a bioactive effect? The team of López-Nicolás J.M. (University of Murcia, Spain) has recently published a curious